Gretel D'souza
Rheumatology · Sylmar, CANPI 1679138531
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,545, more than ten times the $192 reported in 2022.
Across 162 payments — averaging $36.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$1K
- AstraZeneca$740
- Johnson & Johnson$548
- Novartis$496
- GSK$419
- plus $1K from 9 others
What the payments were for
- Food & beverage$5,69497%
- Education$1823%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 29 | $1,286 |
| AbbVie | 36 | $1,135 |
| AstraZeneca(2 entities) | 13 | $740 |
| Johnson & Johnson | 15 | $548 |
| Novartis | 18 | $496 |
| GSK | 21 | $419 |
| UCB, Inc. | 10 | $401 |
| Aurinia Pharma U.S., Inc. | 4 | $217 |
| Janssen Scientific Affairs, LLC | 2 | $175 |
| Actelion Pharmaceuticals US, Inc. | 1 | $119 |
| ANI Pharmaceuticals, Inc. | 3 | $94 |
| Mallinckrodt Hospital Products Inc. | 4 | $93 |
| Boehringer Ingelheim | 4 | $90 |
| Octapharma USA, Inc. | 1 | $37 |
| Fresenius Kabi USA, LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,876 in reported general payments places this provider in the 60th percentile of 808 rheumatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 26 | $1,506 |
| MethotrexateMethotrexate Sodium | 38 | $709 |
| Omeprazole | 17 | $343 |
| Pilocarpine Hcl | 13 | $287 |
| Prednisone | 16 | $118 |
| Gabapentin | 14 | $102 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Sylmar
- Sudhakar TumuluriSan Francisco$2.8M
- Ara DikranianSan Diego$2.2M
- Orrin TroumSanta Monica$1.8M
- Robin DoreTustin$1.5M
- Samy MetyasCovina$1.3M
- Rhonda LambertSan Mateo$1.1M
- William ShielMission Viejo$924K
- Mark BoriginiDowney$920K
- Adam KreitenbergTarzana$863K
- Roger KornuTustin$802K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.